Download Full Issue PDF (10.3 MB)
Obituary
Reviews
Oral antiplatelet agents in cardiovascular disease
- Joseph Pultar,
- Patricia P. Wadowski,
- Simon Panzer,
- Thomas Gremmel
Vol. 48, Issue 4 • October 16, 2018, pp. 291–302
Potential mechanisms for the effects of far-infrared on the cardiovascular system – a review
- Richard Shemilt,
- Hala Bagabir,
- Chim Lang,
- Faisel Khan
Vol. 48, Issue 4 • November 13, 2018, pp. 303–312
Original communications
Gamma-glutamyl transferase as a risk factor for mortality and cardiovascular events in older adults – results from a prospective cohort study in a primary care setting (getABI)
- Florian Kreutzer,
- Dietmar Krause,
- Renate Klaassen-Mielke,
- Hans-Joachim Trampisch,
- Curt Diehm,
- Henrik Rudolf
Vol. 48, Issue 4 • April 17, 2019, pp. 313–319
Anticoagulation in addition to dual antiplatelet therapy has no impact on long-term follow-up after endovascular treatment of (sub)acute lower limb ischemia
- Mariya Kronlage,
- Erwin Blessing,
- Oliver J. Müller,
- Britta Heilmeier,
- Hugo A. Katus,
- Christian Erbel
Vol. 48, Issue 4 • April 8, 2019, pp. 321–329
Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis
- Tim Sebastian,
- Rolf P. Engelberger,
- David Spirk,
- Lawrence O. Hakki,
- Frederic A. Baumann,
- Rebecca S. Spescha,
- Nils Kucher
Vol. 48, Issue 4 • January 22, 2019, pp. 331–339
Safety, procedural success and outcome of the Aspirex®S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis – data from the Arnsberg Aspirex registry
- Michael Lichtenberg,
- Wilhelm Friedrich Stahlhoff,
- Ahmet Özkapi,
- Rick de Graaf,
- Frank Breuckmann
Vol. 48, Issue 4 • February 20, 2019, pp. 341–346
Higher preprocedural fibrinogen levels are associated with aneurysm sac regression after EVAR
- Mária Rašiová,
- Martin Koščo,
- Ľubomír Špak,
- Matej Moščovič,
- Jozef Židzik,
- Eva Slabá,
- Viera Habalová,
- Ľudmila Farkašová,
- Marek Hudák,
- Ivan Tkáč
Vol. 48, Issue 4 • March 15, 2019, pp. 347–354
French vascular physicians’ practices in indicating antiplatelet and anticoagulation therapy in venous thromboembolism
- Antoine Fayol,
- Damien Lanéelle,
- Clément Hoffmann,
- Guillaume Mahé,
- Isabelle Mahé
Vol. 48, Issue 4 • April 4, 2019, pp. 355–360
A near-infrared spectroscopy-assisted test discriminates patients with peripheral arterial disease and venous insufficiency with changes of foot oxygenation following light elastic compression therapy
- Nicola Lamberti,
- Fabio Manfredini,
- Mirko Tessari,
- Erica Menegatti,
- Francesca Nardi,
- Nino Basaglia,
- Paolo Zamboni
Vol. 48, Issue 4 • March 6, 2019, pp. 361–367
Case report
Acquired arteriovenous fistula of a finger
- Roderich Rietig,
- Sarah Hudak,
- Anja Hieronimus,
- Angela Lehn-Stefan,
- Bernd Balletshofer,
- Hans-Ulrich Häring,
- Roland Syha,
- Elko Randrianarisoa
Vol. 48, Issue 4 • March 15, 2019, pp. 368–370
Journal club
Optimized cardiovascular risk in peripheral arterial disease – does intensified statin therapy matter?
- Kristina Sonnenschein,
- Jörn Tongers
Vol. 48, Issue 4 • June 24, 2019, pp. 371–372